Hepatolactone, also known as glucuronide tablets, is a hepatoprotective drug. After entering the body, it can combine with toxic substances containing hydroxyl or carboxyl groups to form low or non-toxic conjugates that are excreted in the urine, thus having a protective as well as detoxifying effect on the liver. In addition, glucuronide increases liver glycogen content and decreases fat stores, and is used clinically as an adjunct to the treatment of acute and chronic hepatitis. When using this drug, it should be noted that it is an adjunctive treatment drug for liver disease and liver function should be checked regularly at the hospital during treatment. In addition, patients may occasionally experience flushing and mild gastrointestinal discomfort during use, and these side effects can be gradually relieved after the dosage is generally reduced or discontinued. In conclusion, hepatocyte is a liver-protective drug, which is used to protect the liver and is used as an adjunctive treatment for acute and chronic hepatitis.